67
Participants
Start Date
March 5, 2021
Primary Completion Date
April 18, 2022
Study Completion Date
August 18, 2022
Affirm Contrast Biopsy procedure
Contrast Enhanced Digital Mammography (CEDM) is an extension of the existing indication for diagnostic mammography with the Selenia Dimensions system and 3Dimensions system. Biopsy targeting can be done on captured contrast enhanced images (scout and stereo pair). The CEDM application shall enable contrast enhanced breast imaging using a dual energy technique. This imaging technique can be used as an adjunct following mammography and/or ultrasound exams to localize a known or suspected lesion. Affirm Contrast Biopsy is intended for patients recommended for biopsy who have had a suspicious finding on previous contrast enhanced imaging or have lesions that may be occult under other modalities.
University of Pittsburgh Medical Center, Pittsburgh
Mayo Clinic, Phoenix
Lead Sponsor
Hologic, Inc.
INDUSTRY